Concepts (193)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Esophageal Diseases | 3 | 2019 | 34 | 1.63 | Why? |
| Catheter Ablation | 4 | 2019 | 438 | 1.28 | Why? |
| Esophagus | 3 | 2019 | 139 | 0.95 | Why? |
| Hemobilia | 1 | 2019 | 2 | 0.81 | Why? |
| Esophagitis | 1 | 2019 | 21 | 0.81 | Why? |
| Gastrointestinal Hemorrhage | 4 | 2019 | 669 | 0.80 | Why? |
| Hereditary Angioedema Type III | 1 | 2018 | 1 | 0.80 | Why? |
| Ankle Fractures | 1 | 2019 | 16 | 0.78 | Why? |
| Pancreatic Pseudocyst | 1 | 2019 | 23 | 0.78 | Why? |
| Melena | 1 | 2019 | 30 | 0.77 | Why? |
| Respiratory Paralysis | 1 | 2018 | 16 | 0.77 | Why? |
| Colitis | 2 | 2020 | 266 | 0.76 | Why? |
| Ankle Joint | 1 | 2019 | 42 | 0.76 | Why? |
| Acyclovir | 1 | 2019 | 154 | 0.74 | Why? |
| Paresis | 1 | 2018 | 77 | 0.72 | Why? |
| Intraabdominal Infections | 1 | 2018 | 90 | 0.70 | Why? |
| Cocaine-Related Disorders | 1 | 2018 | 51 | 0.70 | Why? |
| Cocaine | 1 | 2018 | 73 | 0.70 | Why? |
| Peritoneal Neoplasms | 1 | 2018 | 110 | 0.69 | Why? |
| Aneurysm, False | 1 | 2019 | 88 | 0.69 | Why? |
| Triiodothyronine | 1 | 2018 | 201 | 0.68 | Why? |
| Pulmonary Veins | 1 | 2019 | 146 | 0.67 | Why? |
| Electrophysiology | 1 | 2017 | 64 | 0.65 | Why? |
| Therapeutic Irrigation | 1 | 2017 | 167 | 0.62 | Why? |
| Foramen Ovale, Patent | 1 | 2018 | 153 | 0.62 | Why? |
| Herpes Simplex | 1 | 2019 | 272 | 0.61 | Why? |
| Heart Atria | 1 | 2019 | 267 | 0.61 | Why? |
| Intestinal Diseases | 1 | 2018 | 231 | 0.60 | Why? |
| Takotsubo Cardiomyopathy | 2 | 2019 | 453 | 0.59 | Why? |
| Electrophysiologic Techniques, Cardiac | 1 | 2019 | 396 | 0.57 | Why? |
| Atrial Fibrillation | 2 | 2019 | 2320 | 0.51 | Why? |
| Acquired Immunodeficiency Syndrome | 1 | 2019 | 533 | 0.49 | Why? |
| Adenocarcinoma | 1 | 2018 | 651 | 0.44 | Why? |
| Lymphohistiocytosis, Hemophagocytic | 1 | 2019 | 800 | 0.42 | Why? |
| Fatal Outcome | 5 | 2019 | 3438 | 0.40 | Why? |
| Carcinoma, Hepatocellular | 1 | 2018 | 1222 | 0.36 | Why? |
| Simulation Training | 1 | 2017 | 957 | 0.32 | Why? |
| Liver Neoplasms | 1 | 2018 | 1666 | 0.31 | Why? |
| Dietary Supplements | 1 | 2018 | 2251 | 0.31 | Why? |
| Necrosis | 2 | 2019 | 532 | 0.30 | Why? |
| Tachycardia, Ventricular | 2 | 2018 | 251 | 0.29 | Why? |
| Diagnosis, Differential | 8 | 2019 | 7220 | 0.28 | Why? |
| Antineoplastic Agents | 1 | 2018 | 3550 | 0.24 | Why? |
| Clinical Competence | 1 | 2017 | 3263 | 0.23 | Why? |
| Zinc Sulfate | 1 | 2020 | 35 | 0.21 | Why? |
| Pulmonary Embolism | 1 | 2019 | 4775 | 0.19 | Why? |
| Xiphoid Bone | 1 | 2018 | 1 | 0.19 | Why? |
| Metronidazole | 1 | 2019 | 59 | 0.19 | Why? |
| Speech Disorders | 1 | 2019 | 55 | 0.19 | Why? |
| Postural Orthostatic Tachycardia Syndrome | 1 | 2019 | 52 | 0.19 | Why? |
| Choledocholithiasis | 1 | 2018 | 33 | 0.18 | Why? |
| Neurotoxicity Syndromes | 1 | 2019 | 124 | 0.18 | Why? |
| Vascular Diseases | 2 | 2017 | 846 | 0.18 | Why? |
| Fluoroscopy | 1 | 2018 | 140 | 0.18 | Why? |
| Hemostasis, Endoscopic | 1 | 2017 | 24 | 0.18 | Why? |
| Gastrostomy | 1 | 2018 | 56 | 0.17 | Why? |
| Gastric Outlet Obstruction | 1 | 2017 | 14 | 0.17 | Why? |
| Biophysical Phenomena | 1 | 2017 | 78 | 0.17 | Why? |
| Torsion Abnormality | 1 | 2017 | 20 | 0.17 | Why? |
| Angiography | 1 | 2019 | 301 | 0.17 | Why? |
| Endoscopy, Digestive System | 2 | 2019 | 352 | 0.17 | Why? |
| Fracture Fixation, Internal | 1 | 2019 | 188 | 0.17 | Why? |
| Death, Sudden | 1 | 2019 | 160 | 0.17 | Why? |
| Nocardia Infections | 1 | 2017 | 37 | 0.16 | Why? |
| Thyrotropin | 1 | 2018 | 262 | 0.16 | Why? |
| Brain Abscess | 1 | 2017 | 50 | 0.16 | Why? |
| Thyroxine | 1 | 2018 | 250 | 0.16 | Why? |
| Endpoint Determination | 1 | 2018 | 344 | 0.16 | Why? |
| Hypokalemia | 1 | 2018 | 195 | 0.16 | Why? |
| Antiemetics | 1 | 2017 | 75 | 0.16 | Why? |
| Haloperidol | 1 | 2017 | 78 | 0.16 | Why? |
| Lymphoma, Mantle-Cell | 1 | 2017 | 109 | 0.16 | Why? |
| Anemia, Iron-Deficiency | 1 | 2018 | 210 | 0.15 | Why? |
| Testicular Neoplasms | 1 | 2017 | 91 | 0.15 | Why? |
| Atrioventricular Block | 1 | 2017 | 105 | 0.15 | Why? |
| Neoplasms, Germ Cell and Embryonal | 1 | 2017 | 106 | 0.15 | Why? |
| Syncope | 1 | 2019 | 238 | 0.15 | Why? |
| Reoperation | 1 | 2019 | 544 | 0.15 | Why? |
| Intestinal Perforation | 1 | 2018 | 178 | 0.15 | Why? |
| Embolization, Therapeutic | 1 | 2019 | 269 | 0.15 | Why? |
| Acute Disease | 2 | 2019 | 6029 | 0.15 | Why? |
| Abdomen | 1 | 2019 | 424 | 0.15 | Why? |
| Marijuana Abuse | 1 | 2017 | 111 | 0.15 | Why? |
| Cholangiopancreatography, Endoscopic Retrograde | 1 | 2018 | 237 | 0.14 | Why? |
| Echocardiography, Transesophageal | 1 | 2018 | 447 | 0.14 | Why? |
| Torsades de Pointes | 1 | 2017 | 229 | 0.14 | Why? |
| Cannabinoids | 1 | 2017 | 134 | 0.14 | Why? |
| Fatty Liver | 1 | 2018 | 299 | 0.14 | Why? |
| Rectum | 1 | 2017 | 495 | 0.13 | Why? |
| Awareness | 1 | 2019 | 529 | 0.13 | Why? |
| Proton Pump Inhibitors | 1 | 2019 | 377 | 0.13 | Why? |
| Nausea | 1 | 2017 | 457 | 0.13 | Why? |
| Cardiovascular Agents | 1 | 2019 | 663 | 0.12 | Why? |
| Rhabdomyolysis | 1 | 2017 | 287 | 0.12 | Why? |
| Colon | 1 | 2017 | 669 | 0.12 | Why? |
| Fluid Therapy | 1 | 2017 | 628 | 0.12 | Why? |
| HIV | 1 | 2019 | 1116 | 0.12 | Why? |
| Endocarditis, Bacterial | 1 | 2017 | 344 | 0.11 | Why? |
| Vomiting | 1 | 2017 | 722 | 0.11 | Why? |
| Treatment Outcome | 10 | 2021 | 51732 | 0.11 | Why? |
| Alcoholism | 1 | 2019 | 691 | 0.11 | Why? |
| Mouth Neoplasms | 1 | 2018 | 463 | 0.11 | Why? |
| Colonoscopy | 1 | 2017 | 738 | 0.11 | Why? |
| Humans | 29 | 2021 | 930598 | 0.11 | Why? |
| Male | 18 | 2021 | 367725 | 0.10 | Why? |
| Electrocardiography | 3 | 2019 | 3957 | 0.10 | Why? |
| Opportunistic Infections | 1 | 2017 | 602 | 0.10 | Why? |
| Heart Arrest | 1 | 2021 | 1239 | 0.10 | Why? |
| Disseminated Intravascular Coagulation | 1 | 2019 | 994 | 0.10 | Why? |
| Anti-Infective Agents | 2 | 2019 | 1766 | 0.10 | Why? |
| Hypertension, Pulmonary | 1 | 2018 | 970 | 0.10 | Why? |
| Blood Transfusion | 1 | 2019 | 1399 | 0.09 | Why? |
| Carcinoma, Squamous Cell | 1 | 2018 | 902 | 0.09 | Why? |
| Stroke Volume | 1 | 2019 | 2153 | 0.09 | Why? |
| Recurrence | 1 | 2019 | 3675 | 0.09 | Why? |
| Crohn Disease | 1 | 2017 | 959 | 0.09 | Why? |
| Echocardiography | 2 | 2019 | 3661 | 0.09 | Why? |
| Cardiopulmonary Resuscitation | 1 | 2021 | 1876 | 0.08 | Why? |
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2017 | 1573 | 0.08 | Why? |
| Hydroxychloroquine | 2 | 2020 | 12447 | 0.08 | Why? |
| Equipment Design | 1 | 2017 | 3095 | 0.08 | Why? |
| Antiviral Agents | 1 | 2019 | 41703 | 0.08 | Why? |
| Renin-Angiotensin System | 1 | 2021 | 3661 | 0.07 | Why? |
| Female | 13 | 2021 | 380317 | 0.07 | Why? |
| Azithromycin | 1 | 2020 | 3943 | 0.07 | Why? |
| Angiotensin Receptor Antagonists | 1 | 2021 | 3892 | 0.07 | Why? |
| Middle Aged | 10 | 2021 | 270681 | 0.07 | Why? |
| Adult | 8 | 2020 | 244371 | 0.07 | Why? |
| Hypoxia | 1 | 2018 | 3626 | 0.06 | Why? |
| African Americans | 1 | 2019 | 3363 | 0.06 | Why? |
| Palliative Care | 1 | 2018 | 2665 | 0.06 | Why? |
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2021 | 5277 | 0.06 | Why? |
| Hematopoietic Stem Cell Transplantation | 1 | 2017 | 2426 | 0.06 | Why? |
| Computer Simulation | 1 | 2017 | 4982 | 0.06 | Why? |
| Aged | 10 | 2021 | 215776 | 0.06 | Why? |
| Astringents | 1 | 2020 | 10 | 0.06 | Why? |
| Contraindications, Drug | 1 | 2021 | 281 | 0.05 | Why? |
| Radiography, Abdominal | 1 | 2020 | 88 | 0.05 | Why? |
| Algorithms | 1 | 2017 | 7346 | 0.05 | Why? |
| Tilt-Table Test | 1 | 2019 | 20 | 0.05 | Why? |
| Tomography, X-Ray Computed | 4 | 2020 | 25144 | 0.05 | Why? |
| Antibodies, Monoclonal, Humanized | 1 | 2020 | 9335 | 0.05 | Why? |
| Ifosfamide | 1 | 2017 | 10 | 0.04 | Why? |
| Sulfadoxine | 1 | 2017 | 14 | 0.04 | Why? |
| Trimethoprim | 1 | 2017 | 22 | 0.04 | Why? |
| Stomach Diseases | 1 | 2017 | 27 | 0.04 | Why? |
| Carboplatin | 1 | 2017 | 76 | 0.04 | Why? |
| Gastritis | 1 | 2017 | 66 | 0.04 | Why? |
| Surgical Instruments | 1 | 2017 | 145 | 0.04 | Why? |
| Paclitaxel | 1 | 2017 | 124 | 0.04 | Why? |
| Etoposide | 1 | 2017 | 115 | 0.04 | Why? |
| Stomach | 1 | 2017 | 141 | 0.04 | Why? |
| Hospital Mortality | 1 | 2020 | 22087 | 0.04 | Why? |
| Speech | 1 | 2019 | 241 | 0.04 | Why? |
| Aged, 80 and over | 4 | 2019 | 88759 | 0.04 | Why? |
| Endoscopy, Gastrointestinal | 2 | 2017 | 1545 | 0.04 | Why? |
| Transplantation, Autologous | 1 | 2017 | 364 | 0.04 | Why? |
| Internship and Residency | 1 | 2017 | 4987 | 0.04 | Why? |
| Dizziness | 1 | 2017 | 275 | 0.04 | Why? |
| Epinephrine | 1 | 2017 | 323 | 0.03 | Why? |
| Arteries | 1 | 2017 | 283 | 0.03 | Why? |
| Observational Studies as Topic | 1 | 2021 | 1887 | 0.03 | Why? |
| Vasoconstrictor Agents | 1 | 2017 | 714 | 0.03 | Why? |
| Mitral Valve Insufficiency | 1 | 2017 | 302 | 0.03 | Why? |
| Multimodal Imaging | 1 | 2017 | 534 | 0.03 | Why? |
| Syndrome | 1 | 2017 | 1310 | 0.03 | Why? |
| Weight Loss | 1 | 2017 | 826 | 0.03 | Why? |
| Odds Ratio | 1 | 2020 | 5861 | 0.02 | Why? |
| Antimalarials | 1 | 2020 | 2505 | 0.02 | Why? |
| Drug Combinations | 1 | 2017 | 3852 | 0.02 | Why? |
| Disease Progression | 1 | 2021 | 13580 | 0.01 | Why? |
| Randomized Controlled Trials as Topic | 1 | 2021 | 10649 | 0.01 | Why? |
| Pneumonia, Viral | 2 | 2020 | 243684 | 0.01 | Why? |
| Coronavirus Infections | 2 | 2020 | 253789 | 0.01 | Why? |
| Mortality | 1 | 2018 | 7132 | 0.01 | Why? |
| Hospitals | 1 | 2021 | 11793 | 0.01 | Why? |
| Host-Pathogen Interactions | 1 | 2021 | 11041 | 0.01 | Why? |
| Immunocompromised Host | 1 | 2017 | 5150 | 0.01 | Why? |
| Magnetic Resonance Imaging | 1 | 2017 | 6551 | 0.01 | Why? |
| Follow-Up Studies | 1 | 2018 | 17020 | 0.01 | Why? |
| Prevalence | 1 | 2021 | 25773 | 0.01 | Why? |
| Registries | 1 | 2018 | 12327 | 0.01 | Why? |
| Anti-Bacterial Agents | 1 | 2020 | 10083 | 0.01 | Why? |
| Prognosis | 1 | 2021 | 32490 | 0.01 | Why? |
| Risk Assessment | 1 | 2021 | 25439 | 0.01 | Why? |
| Young Adult | 2 | 2019 | 93724 | 0.01 | Why? |
| Betacoronavirus | 1 | 2020 | 204454 | 0.01 | Why? |
| Pandemics | 2 | 2020 | 389249 | 0.01 | Why? |
| Cohort Studies | 1 | 2018 | 36005 | 0.01 | Why? |
| Prospective Studies | 1 | 2018 | 43301 | 0.01 | Why? |
| Risk Factors | 1 | 2021 | 71621 | 0.01 | Why? |
| Hospitalization | 1 | 2020 | 54280 | 0.01 | Why? |
| Retrospective Studies | 1 | 2020 | 105322 | 0.01 | Why? |
Ullah's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(193)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(91)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_